<DOC>
	<DOCNO>NCT00380640</DOCNO>
	<brief_summary>The purpose study assess efficacy trimethoprim promote wound heal decrease blister formation patient Epidermolysis Bullosa .</brief_summary>
	<brief_title>The Efficacy Trimethoprim Wound Healing Patients With Epidermolysis Bullosa</brief_title>
	<detailed_description>Epidermolysis Bullosa ( EB ) comprise series hereditary disorder characterize fragility skin mucous membrane tendency skin blister response minor friction trauma . The care patient EB complex task carry multi-professional team . In absence cure , goal therapy prevention heal chronic wound . In patient EB , chronic inflammation interfere proper wound heal . One treatment option use anti-inflammatory antimicrobial agent , trimethoprim , hasten wound heal decrease blister formation . This treatment may lead decreased pain improvement quality life patient .</detailed_description>
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<criteria>Patients young 20 year age Diagnosis Recessive Dystrophic Epidermis Bullosa ( RDEB ) Junctional Epidermis Bullosa ( JEB ) Signed consent/assent form Previous know allergy intolerance trimethoprim</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Pediatrics</keyword>
	<keyword>Epidermolysis Bullosa</keyword>
	<keyword>Trimethoprim</keyword>
	<keyword>Wound Healing</keyword>
</DOC>